C. Gagnon

Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.

T. Di Paolo, P. Bédard, C. Gagnon, 1990, European journal of pharmacology.

Effect of adding the D1 agonist CY 208–243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors

T. Di Paolo, P. Bédard, B. Gomez-Mancilla, 1993, Movement disorders : official journal of the Movement Disorder Society.

Grafts in the Treatment of Parkinson's Disease: Animal Models

P. Bédard, C. Gagnon, T. Paolo, 1993, Reviews in the neurosciences.

A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections ofl-dopa in 6-ohda rats. Correlation with D1 and D2 receptors

T. Paolo, P. Be´dard, C. Gagnon, 1993, Neuroscience.

Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants

P. Bédard, T. Paolo, C. Gagnon, 1991, Neuroscience.

Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys.

P. Bédard, B. Gomez-Mancilla, P. Falardeau, 1993, Advances in neurology.

Chronic CY 208–243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors

P. Bédard, B. Gomez-Mancilla, T. Paolo, 1993, Neuroscience Letters.

Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat

M. Martinoli, G. Pelletier, T. Paolo, 1991, Brain Research.

Levodopa-Induced Dyskinesia: Facts and Fancy. What Does the MPTP Monkey Model Tell Us?

T. Di Paolo, P. Bédard, C. Gagnon, 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors

P. Bédard, B. Gomez-Mancilla, T. Paolo, 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.